Biosimilars & Generics in the Pre-Emerging and Emerging Markets
-
You work in the field of branded generics, biosimilars or the so called generic plus products? Then this seminar will help you to identify new and upcoming markets outside the EU.50.10814 8.66164
| Wann |
06.12.2013 von 09:00 bis 17:00 |
|---|---|
| Veranstaltungsort | Steigenberger Metropolitan |
| Stadt | Frankfurt |
| Kontaktname | Dr. Henriette Wolf-Klein |
| Kontakttelefon | 06221 500 680 |
| Zielgruppe |
This seminar addresses the needs of those working in the generics and biosimilar industry. Especialls managing directors and managers from the following divisions will benefit from this course: - R & D and regulatory affairs - business development - market access & sales |
| Termin übernehmen |
vCal
iCal
|
You will learn about the global regulatory framework for biosimilars in the various countries and why you don't always need to be the first on the market. You'll also get to know the opportunities still available for branded generics outside the EU now and in the near future.
After having completed this seminar you will have a set of concrete ideas on how you could further improve your business development globally.
Topics:
- Risks and rewards of being late with biosimilars
- China - a market for European generic plus products
- How European companies can better penetrate LATAM
- Using branded generics for expansion into emerging markets
- The biosimilar global regulatory environment
Weitere Informationen über diesen Termin…
FORUM Institut für Management GmbH
Programm
FORUM_Logo_JPEG.jpg
—
JPEG image,
599 kB (613,761 bytes)
